Aug 12, 2021 / 09:00PM GMT
Operator
Good afternoon, and welcome to AbCellera's Second Quarter 2021 Financial Results Conference Call. My name is Mel, and I will facilitate the audio portion of today's interactive broadcast. (Operator Instructions) And please be advised that this conference is being recorded.
At this time, I would like to turn the call over to Mr. Tryn Stimart, AbCellera's Chief Legal Officer and Chief Compliance Officer. Sir, please go ahead.
Tryn T. Stimart - AbCellera Biologics Inc. - Chief Legal Officer, Chief Compliance Officer & Corporate Secretary
Thank you. Good afternoon, everyone, and welcome to AbCellera's Second Quarter 2021 Business Update. We are pleased to have you with us today where we will discuss the results announced in our press release issued after the market closed today, which you can find on our Investor Relations website.
With me on the call are Dr. Carl Hansen, AbCellera's Chief Executive Officer and President; Andrew Booth, AbCellera's Chief Financial Officer. The webcast portion of this call contains a slide presentation that we
Q2 2021 Abcellera Biologics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot